Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles
HK Stock Market Move | METIS TECHBIO-P(07666) rose nearly 5% and formed a strategic alliance with Deerfield to jointly develop AI-driven protein drugs and in vivo immune therapy.
Guotai Haitong: The value of metal leaders in the configuration is highlighted, and the long-term outlook for rare earth investment value is promising.
HK Stock Market Move | INGDAN (00400) increases by more than 18% again AI infrastructure competition has shifted to system efficiency optimization The company has sufficient orders and improved operations.
HK Stock Market Move | METIS TECHBIO-P(07666) rose nearly 5% and formed a strategic alliance with Deerfield to jointly develop AI-driven protein drugs and in vivo immune therapy.
Guotai Haitong: The value of metal leaders in the configuration is highlighted, and the long-term outlook for rare earth investment value is promising.
HK Stock Market Move | INGDAN (00400) increases by more than 18% again AI infrastructure competition has shifted to system efficiency optimization The company has sufficient orders and improved operations.
